- Home
- JJSF vs JANX Comparison
JJSF vs JANX Comparison
Compare JJSF & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JJSF
- JANX
- Stock Information
- Founded
- JJSF 1971
- JANX 2017
- Country
- JJSF United States
- JANX United States
- Employees
- JJSF N/A
- JANX N/A
- Industry
- JJSF Specialty Foods
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- JJSF Consumer Staples
- JANX Health Care
- Exchange
- JJSF Nasdaq
- JANX Nasdaq
- Market Cap
- JJSF 2.6B
- JANX 2.2B
- IPO Year
- JJSF N/A
- JANX 2021
- Fundamental
- Price
- JJSF $129.29
- JANX $36.01
- Analyst Decision
- JJSF Buy
- JANX Strong Buy
- Analyst Count
- JJSF 2
- JANX 11
- Target Price
- JJSF $167.50
- JANX $83.09
- AVG Volume (30 Days)
- JJSF 162.3K
- JANX 821.6K
- Earning Date
- JJSF 02-03-2025
- JANX 03-07-2025
- Dividend Yield
- JJSF 2.42%
- JANX N/A
- EPS Growth
- JJSF 5.09
- JANX N/A
- EPS
- JJSF 4.32
- JANX N/A
- Revenue
- JJSF $1,589,045,000.00
- JANX $13,049,000.00
- Revenue This Year
- JJSF $5.60
- JANX $39.66
- Revenue Next Year
- JJSF $3.19
- JANX N/A
- P/E Ratio
- JJSF $30.03
- JANX N/A
- Revenue Growth
- JJSF 2.14
- JANX 54.12
- 52 Week Low
- JJSF $116.60
- JANX $14.68
- 52 Week High
- JJSF $180.80
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- JJSF 43.54
- JANX 34.78
- Support Level
- JJSF $122.96
- JANX $36.13
- Resistance Level
- JJSF $130.53
- JANX $38.13
- Average True Range (ATR)
- JJSF 4.22
- JANX 2.52
- MACD
- JJSF 0.91
- JANX 0.08
- Stochastic Oscillator
- JJSF 63.93
- JANX 5.71
About JJSF J & J Snack Foods Corp.
J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.